Biggest News Aggregation in the World
📰 Aktx News

Page 2 - Aktx News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Aktx. Real-time updates on events, politics, business and more.

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report sent to investors on Monday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Akari Therapeutics stock opened at $3.60 on Monday. Akari Therapeutics has a twelve month low of $2.81 and a […]
Cerity Partners Akari Therapeutics Plc Sabby Management Renaissance Technologies Zakari Therapeutics Free Report
Source: wkrb13.com

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Up 1.2 % NASDAQ AKTX opened at $3.45 on Friday. Akari Therapeutics has a 12 month low of $2.81 and a 12 […]
Sabby Management Akari Therapeutics Plc Cerity Partners Akari Therapeutics Company Profile Renaissance Technologies Zakari Therapeutics
Source: wkrb13.com

Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of NASDAQ AKTX opened at $3.45 on Friday. The business has a 50 day simple moving average of $3.67 and a […]
Sabby Management Akari Therapeutics Plc Renaissance Technologies Cerity Partners Zakari Therapeutics Free Report

Akari Therapeutics (NASDAQ:AKTX) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Friday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance Shares of Akari Therapeutics stock opened at $3.88 on Friday. The company’s fifty day moving average price is $3.96 and […]
Sabby Management Akari Therapeutics Plc Akari Therapeutics Company Profile Renaissance Technologies Cerity Partners Zakari Therapeutics

Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance Shares of NASDAQ:AKTX opened at $3.61 on Friday. The firm has a fifty day moving average of $3.84 and a 200 […]
Renaissance Technologies Cerity Partners Akari Therapeutics Company Profile Sabby Management Akari Therapeutics Plc Zakari Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report released on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Price Performance AKTX opened at $3.61 on Friday. The stock has a market capitalization of $13.44 million, a P/E ratio of -0.52 […]
Renaissance Technologies Cerity Partners Akari Therapeutics Plc Akari Therapeutics Company Profile Sabby Management Zakari Therapeutics
Source: wkrb13.com

Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 22.3 % Shares of Akari Therapeutics stock opened at $0.19 on Friday. The firm has a market cap of $14.03 […]
Cerity Partners Akari Therapeutics Plc Akari Therapeutics Company Profile Sabby Management Renaissance Technologies Zakari Therapeutics

Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 0.1 % Shares of NASDAQ:AKTX opened at $0.27 on Friday. The firm’s 50-day moving average is $0.18 and its […]
Akari Therapeutics Plc Sabby Management Renaissance Technologies Zakari Therapeutics Free Report Get Free Report

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 2.8 % AKTX stock opened at $0.22 on Thursday. Akari Therapeutics has a 1 year low of $0.14 and a 1 […]
Akari Therapeutics Company Profile Sabby Management Akari Therapeutics Plc Renaissance Technologies Zakari Therapeutics Free Report

StockNews.com Begins Coverage on Akari Therapeutics (NASDAQ:AKTX)

StockNews.com started coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Performance AKTX opened at $0.17 on Wednesday. The company has a fifty day moving average price of $0.17 and a […]
Sabby Management Akari Therapeutics Plc Renaissance Technologies Zakari Therapeutics Free Report Get Free Report

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science